Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Republicans in the US Senate have said they will spare the US-backed HIV/Aids programme Pepfar from cuts, amid a larger ...

Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...

The move to save PEPFAR funding may prove useful in rallying GOP support from powerful lawmakers like Senate Appropriations ...

State attorneys general and federal prosecutors alleged Gilead Sciences illegally bankrolled lavish events for prescribers.

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...